Oxidative stress and endothelial function in chronic renal failure

Journal of the American Society of Nephrology

Volumn 12, Issue 12, 2001, Pages 2747-2752

  Annuk, M ^a   Zilmer, M ^a   Lind, L ^a   Linde, T ^a   Fellstrom B ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALKADIENE; GLUTATHIONE; LIPID HYDROPEROXIDE; LIPOPROTEIN; METHACHOLINE; NITROPRUSSIDE SODIUM; THIOBARBITURIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CELL FUNCTION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; FLOW MEASUREMENT; FOREARM BLOOD FLOW; HUMAN; MALE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; VASODILATATION; VEIN OCCLUSION;

EID: 0035204104     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v12122747     Document Type: Article

References (35)

1. Cardiovascular disease in chronic renal failure. Clinical epidemiology of cardiovascular disease in chronic renal failure
2. Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus
3. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension
4. Impaired vasodilatation of forearm resistance vessels in hypercholesterolemic humans
5. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoralis and normal coronary angiograms
6. Systemic nature of endothelial dysfunction in atherosclerosis
7. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae
8. Evidence for a possible role of oxygen free radicals in the abnormal functional arterial vasomotion in insulin dependent diabetes
9. Lipid peroxidation and endothelial cell injury: Implications in atherosclerosis
10. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure
11. Thiobarbituric acid reactive material in uremic blood
12. Abnormal antioxidant vitamin and carotenoid status in chronic renal failure
13. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure
14. Impaired endothelium-dependent vasodilatation in renal failure in humans
15. Physiology and biochemistry of endothelial function in children with chronic renal failure
16. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients
17. Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis
18. Low nitric oxide production in patients with chronic renal failure
19. Effects of low-dose aspirin on the markers of oxidative stress
20. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues
21. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine
22. Hypoxia increases the susceptibility of pulmonary artery endothelial cells to hydrogen peroxide injury
23. A rapid and simple method for measuring the susceptibility of low-densitylipoprotein and very-low-density-lipoprotein to copper-catalyzed oxidation
24. Plethysmographic measurement of peripheral circulatory parameters in man
25. Measuring forearm blood flow and interpreting the responses to drugs and mediators
26. Evaluation of endothelium-dependent vasodilatation in the human peripheral circulation
27. Methodological aspects of the evaluation of endothelium-dependent vasodilatation in the human forearm
28. Endothelium-derived nitric oxide and vascular physiology and pathology
29. Glutathione and its associated enzymes in peripheral blood cells in different stages of renal insufficiency
30. Erythrocyte redox state in uremic anemia: Effects of hemodialysis and relevance of glutathione metabolism
31. Baseline diene conjugation in LDL lipids: An indicator of circulating oxidized LDL
32. Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease
33. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man
34. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial